✦ LIBER ✦

PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Scribed by RC Wielage; CE Muehlenbein; AM Liepa; SM Babineaux; RW Klein; LS Schwartzberg

Book ID: 118610855
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 92 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)73257-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN25 THE BUDGETARY IMPACT OF PEMETREXED

PCN25 THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

✍ R Klein; AH Lawson; CE Muehlenbein; AM Liepa; RC Wielage; S Babineaux; AG Kouste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Pemetrexed monotherapy and pemetrexed pl

Pemetrexed monotherapy and pemetrexed plus platinum combination therapy as non-first-line treatments for advanced non-small cell lung cancer

✍ Fang Wang; Gui-fang Guo; Hui-juan Qiu; Xu-xian Chen; Pi-li Hu; Fei-fei Zhou; Wen 📂 Article 📅 2011 🏛 Springer-Verlag ⚖ 236 KB

PCN21 FIRST-LINE BEVACIZUMAB-BASED THERA

PCN21 FIRST-LINE BEVACIZUMAB-BASED THERAPY VERSUS PEMETREXED + CISPLATIN FOR THE TREATMENT OF ADVANCED ADENOCARCINOMA NONSQUAMOUS NON-SMALL CELL LUNG CANCER: INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES

✍ K Berenson; C Chouaid; A Vergnenegre; S Sherman; S Walzer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Pemetrexed as the first-line therapy for

Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer

✍ Xu, Bei; Liu, Peng; Yin, Yongmei; Liu, Ping; Shu, Yongqian 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Phase III Trial of Cisplatin Plus Gemcit

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL

✍ Reck, M.; von Pawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V.; L 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 190 KB

Phase II study of pemetrexed and cisplat

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer

✍ Schmid-Bindert, Gerald; Gebbia, Vittorio; Mayer, Frank; Arriola, Edurne; Márquez 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 694 KB